These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23609121)

  • 1. Bimanual assisted eyelid retraction technique for intravitreal injections.
    Fineman MS; Hsu J; Spirn MJ; Kaiser RS
    Retina; 2013 Oct; 33(9):1968-70. PubMed ID: 23609121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lid splinting eyelid retraction technique: a minimised sterile approach for intravitreal injections.
    Munro M; Williams GR; Ells A; Fielden M; Kherani A; Mitchell P; Ruzicki J; Adatia FA
    Br J Ophthalmol; 2018 Sep; 102(9):1254-1258. PubMed ID: 29246893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents.
    Shah CP; Garg SJ; Vander JF; Brown GC; Kaiser RS; Haller JA;
    Ophthalmology; 2011 Oct; 118(10):2028-34. PubMed ID: 21705087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask.
    Shimada H; Hattori T; Mori R; Nakashizuka H; Fujita K; Yuzawa M
    Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1885-90. PubMed ID: 23389553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Speculum versus Bimanual Lid Retraction during Intravitreal Injection.
    Rahimy E; Fineman MS; Regillo CD; Spirn MJ; Hsu J; Kaiser RS; Maguire JI; Brown GC; Chiang A
    Ophthalmology; 2015 Aug; 122(8):1729-30. PubMed ID: 25726752
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravitreal bevacizumab: safety of multiple doses from a single vial for consecutive patients.
    Ng DS; Kwok AK; Chan CW; Li WW
    Hong Kong Med J; 2012 Dec; 18(6):488-95. PubMed ID: 23223649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of endophthalmitis after intravitreal injection of antivascular endothelial growth factor medications using topical lidocaine gel anesthesia.
    Inman ZD; Anderson NG
    Retina; 2011 Apr; 31(4):669-72. PubMed ID: 21178659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of endophthalmitis and use of antibiotic prophylaxis after intravitreal injections.
    Cheung CS; Wong AW; Lui A; Kertes PJ; Devenyi RG; Lam WC
    Ophthalmology; 2012 Aug; 119(8):1609-14. PubMed ID: 22480743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of endophthalmitis after intravitreal drug injection when topical antibiotics are not required: the diabetic retinopathy clinical research network laser-ranibizumab-triamcinolone clinical trials.
    Bhavsar AR; Googe JM; Stockdale CR; Bressler NM; Brucker AJ; Elman MJ; Glassman AR;
    Arch Ophthalmol; 2009 Dec; 127(12):1581-3. PubMed ID: 20008710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Endophthalmitis after Intravitreal Injection: A Multivariable Analysis Based on Injection Protocol and Povidone Iodine Strength.
    Stem MS; Rao P; Lee IJ; Woodward MA; Faia LJ; Wolfe JD; Capone A; Covert D; Dass AB; Drenser KA; Garretson BR; Hassan TS; Margherio A; Oh KT; Raephaelian PV; Randhawa S; Sneed S; Trese MT; Yedavally S; Williams GA; Ruby AJ
    Ophthalmol Retina; 2019 Jan; 3(1):3-7. PubMed ID: 30929813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on risk of endophthalmitis after intravitreal drug injections and potential impact of elimination of topical antibiotics.
    Bhavsar AR; Stockdale CR; Ferris FL; Brucker AJ; Bressler NM; Glassman AR;
    Arch Ophthalmol; 2012 Jun; 130(6):809-10. PubMed ID: 22801859
    [No Abstract]   [Full Text] [Related]  

  • 12. Incidence of endophthalmitis related to intravitreal injection of bevacizumab and ranibizumab.
    Fintak DR; Shah GK; Blinder KJ; Regillo CD; Pollack J; Heier JS; Hollands H; Sharma S
    Retina; 2008; 28(10):1395-9. PubMed ID: 18827737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of lidocaine gel anesthesia on endophthalmitis rates following intravitreal injection.
    Lad EM; Maltenfort MG; Leng T
    Ophthalmic Surg Lasers Imaging; 2012; 43(2):115-20. PubMed ID: 22283227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pars plana vitrectomy in the management of patients diagnosed with endophthalmitis following intravitreal anti-vascular endothelial growth factor injection.
    Chaudhary KM; Romero JM; Ezon I; Fastenberg DM; Deramo VA
    Retina; 2013; 33(7):1407-16. PubMed ID: 23492945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral simultaneous intravitreal injections in the office setting.
    Bakri SJ; Risco M; Edwards AO; Pulido JS
    Am J Ophthalmol; 2009 Jul; 148(1):66-9.e1. PubMed ID: 19403114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cotton-tip applicator lid retraction technique for controlled intravitreal injection.
    Shrier EM
    Retina; 2014 Jun; 34(6):1244-6. PubMed ID: 24849702
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect on intraocular pressure in patients receiving unilateral intravitreal anti-vascular endothelial growth factor injections.
    Hoang QV; Mendonca LS; Della Torre KE; Jung JJ; Tsuang AJ; Freund KB
    Ophthalmology; 2012 Feb; 119(2):321-6. PubMed ID: 22054994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National survey of the ophthalmic use of anti-vascular endothelial growth factor drugs in Israel.
    Waisbourd M; Goldstein M; Loewenstein A
    Isr Med Assoc J; 2011 Mar; 13(3):141-6. PubMed ID: 21608333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy.
    Hoang QV; Tsuang AJ; Gelman R; Mendonca LS; Della Torre KE; Jung JJ; Freund KB
    Retina; 2013 Jan; 33(1):179-87. PubMed ID: 22990314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lack of delayed intraocular pressure elevation in patients treated with intravitreal injection of bevacizumab and ranibizumab.
    Wehrli SJ; Tawse K; Levin MH; Zaidi A; Pistilli M; Brucker AJ
    Retina; 2012 Jul; 32(7):1295-301. PubMed ID: 22466465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.